Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|March 13, 2024
The Expression and Functionality of CB1R-NMDAR Complexes Are Decreased in A Parkinson's Disease ModelIrene Reyes-Resina, Jaume Lillo, Iu Raïch, et al.
International Journal of Molecular Sciences|May 25, 2024
Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's DiseaseJoan Biel Rebassa, Toni Capó, Jaume Lillo, et al.
International Journal of Molecular Sciences|October 16, 2025
The Interplay Between CB2 and NMDA Receptors in Parkinson's DiseaseIrene Reyes-Resina, Jaume Lillo, Iu Raïch, et al.
Molecules (Basel, Switzerland)|February 26, 2025
Future Perspectives of NMDAR in CNS DisordersToni Capó, Joan Biel Rebassa, Iu Raïch, et al.
International Journal of Molecular Sciences|May 11, 2024
Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer's DiseaseIu Raïch, Jaume Lillo, Joan Biel Rebassa, et al.
Brain Sciences|October 29, 2025
The Orexin System in Addiction: Neuromodulatory Interactions and Therapeutic PotentialToni Capó, Jaume Lillo, Joan Biel Rebassa, et al.
Alzheimer'S Research & Therapy|November 9, 2021
N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptorsRafael Rivas-Santisteban, Alejandro Lillo, Jaume Lillo, et al.
Pharmacological Research|August 23, 2024
Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signalingGemma Navarro, Marc Gómez-Autet, Paula Morales, et al.
Neurobiology of Disease|October 4, 2025
Cannabidiol releases CB1R from A2AR repression in ischemic strokeIu Raïch, Jaume Lillo, Joan Biel Rebassa, et al.
International Journal of Molecular Sciences|November 11, 2022
Antagonization of OX1 Receptor Potentiates CB2 Receptor Function in Microglia from APPSw/Ind Mice ModelIu Raïch, Joan Biel Rebassa, Jaume Lillo, et al.
Pageof 2